Sastasundar Ventures Limited has submitted the Exchange a copy of Revised Scrutinizer's report of Annual General Meeting held on September 26, 2025
HEALTHX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sastasundar Ventures Limited filed the revised voting results of its 36th Annual General Meeting held on September 26, 2025, conducted via video conferencing. All three resolutions were passed with overwhelming majority: (1) Adoption of Audited Standalone and Consolidated Financial Statements for FY ending March 31, 2025 passed with 99.9995% in favor, (2) Re-appointment of Mr. Ravi Kant Sharma (DIN: 00364066) as Director, who retired by rotation, passed with 99.9963% in favor, and (3) Appointment of M/s MKB & Associates as Secretarial Auditor for a five-year term from FY 2025-26 to FY 2029-30 passed with nearly 100% in favor. Out of 3,18,10,500 total outstanding shares, 2,44,40,104 shares (76.83%) were polled through remote e-voting by 97 members. The revision was made only to fix a typographical error in the Total No. of Shares section; vote percentages for and against remain unchanged.
This is a routine procedural filing confirming shareholder approval of standard AGM agenda items. With near-unanimous support on all resolutions, there is no material impact on the stock price or shareholders. The promoter group voted their entire 2.36 crore shareholding in favor, demonstrating continued alignment with management decisions.